For many years, diphtheria and tetanus toxoids, and pertussis vaccine (DTP) have been used in combination in prophylactic vaccines without deleterious effect on the potency of the respective antigens. A few years ago, inactivated poliomyelitis vaccine was combined with DTP to produce a "quadruple antigen" vaccine (DTPP). In this combination, however, the pertussis vaccine was found to be unstable (Massachusetts Department of Public Health, 1960; Pittman, 1962; Edsall et al., 1962) . Stability data submitted in support of license for DTPP and results of potency assays of more than 50 lots made prior to release both by the manufacturers and the Division of Biologics Standards (DBS) showed satisfactory potency. Nevertheless, DTPP was unstable under market conditions (Pittman, 1962) .
For many years, diphtheria and tetanus toxoids, and pertussis vaccine (DTP) have been used in combination in prophylactic vaccines without deleterious effect on the potency of the respective antigens. A few years ago, inactivated poliomyelitis vaccine was combined with DTP to produce a "quadruple antigen" vaccine (DTPP). In this combination, however, the pertussis vaccine was found to be unstable (Massachusetts Department of Public Health, 1960; Pittman, 1962; Edsall et al., 1962) . Stability data submitted in support of license for DTPP and results of potency assays of more than 50 lots made prior to release both by the manufacturers and the Division of Biologics Standards (DBS) showed satisfactory potency. Nevertheless, DTPP was unstable under market conditions (Pittman, 1962) .
In addition to the presence of poliomyelitis vaccine, DTPP differed from DTP in the preservative added. At least since the establishment of a standard of potency for pertussis vaccine in 1949, Merthiolate has been used as the preservative in P, DP, and DTP. Merthiolate was not used in DTPP because free mercury ions are deleterious to the potency of poliomyelitis vaccine. Instead, benzethonium chloride, which had been found acceptable as a preservative in poliomyelitis vaccine, was used (McLean, 1957) .
In this paper, the data presented show that the presence of benzethonium chloride and the absence of Merthiolate were important reasons for the instability of pertussis in DTPP. Data show that the parabens (methyl-and propyl-phydroxybenzoate), which are used extensively in pharmaceuticals and are not deleterious to poliomyelitis vaccine, would not be an acceptable substitute for use in DTPP because they are harmful to the potency of pertussis vaccine. Data suggested that the histamine-sensitizing factor, also, is unstable in the presence of benzethonium chloride or the parabens. preservative vaccines was similar to the stability of the corresponding lot 2 vaccines after 48 hr at 35 C (Table 1 ). The lot 6 benzethonium chloride vaccine was stable for a slightly longer period at 35 C than was the lot 2 vaccine. Parabens vaccines of both lots 2 and 6 were very unstable at 35 C. Effect of varying concentrations of preservatives upon lot 2 pertussis vaccine. It was thought that if a preservative caused degradation, higher concentrations would hasten the process, or, on the other hand, if higher concentrations had no effect, it would be indicative that the preservative was not harmful. To portions of lot 2 vaccine were added increasing concentrations of Merthiolate and benzethonium chloride and one less and one greater concentration of the parabens than were used in the previous experiments. Table 3 gives the potency estimates of the various preparations determined at intervals up to 11 months. The vaccine without preservative, as previously observed, decreased in potency with time. The effect of either benzethonium chloride or the parabens was not graded in relation to concentration. There is a suggestion that the least deterioration was in the presence of the highest concentration of benzethonium chloride, although the potency of the vaccine with the mid-concentration of the parabens was practically nonexistent at 6 months. This amount is commonly used in pharmaceuticals. With the Merthiolatepreserved vaccines, the same potency estimates for a single vaccine were obtained at 3 and 9 months. However, among the three vaccines, the estimates were greater and graded in relation to increasing concentrations of Merthiolate. Experiments are in progress to attempt to verify this observation with other lots of vaccine.
MATERIALS AND METHODS

Preservatives
Histamine-sensitization tests. In pertussis vaccines there is frequently a close relationship between the histamine-sensitizing ability of the vaccine and its ability to protect mice against intracerebral challenge with virulent pertussis organisms (Pittman, 1951; J6o and Pusztai, 1960) . Therefore, it was of interest to determine whether preservatives which were deleterious to the protective antigen also were deleterious to the histamine-sensitizing factor (HSF).
Although based on only a few animals, the results (Table 4) suggest that the HSF of pertussis vaccines preserved with Merthiolate was more stable than the HSF of pertussis vaccines VOL. 13, 1965 be stable during many years of use, when poliomyelitis vaccine was added and the conditions in the DTP were adjusted to be optimal for the less stable poliomyelitis vaccine, then the pertussis-vaccine component became unstable.
It has long been known that Merthiolate is a good preservative for pertussis vaccine, but Merthiolate was not used in DTPP because free mercury ions are deleterious to the potency of poliomyelitis vaccine. Hence, benzethonium chloride, which was not deleterious to poliomyelitis vaccine (McLean, 1957) , was used as the preservative in DTPP.
The results of our study showed that the use of benzethonium chloride was an important reason for instability of the pertussis-vaccine component of DTPP. Under various experimental conditions, Merthiolate-preserved pertussis vaccines were more stable than vaccines preserved with benzethonium chloride. The potency values of vaccines preserved with benzethonium chloride were consistently lower than the values for vaccines of the same lots preserved with Merthiolate. The parabens, which are not harmful to poliomyelitis vaccine (Tracy et al., 1964) (Pivnick, Tracy, and Glass, 1963) . A recent paper by Olson, Eldering, and Graham (1964) showed that saturation of negative sites on the pertussis cell with cations prior to the addition of benzethonium chloride prevented its uptake by the cell and stabilized the antigenic potency of the vaccine. Their results and ours are in agreement in that benzethonium chloride caused a loss of potency of pertussis vaccine and that this loss was enhanced at 35 or 37 C.
The possibility was considered that the poliomyelitis virus, or some constituent of the monkey kidney tissue culture fluid in which the virus was grown, might have a deleterious effect upon the pertussis protective antigen. However, in a limited number of experiments, no evidence was observed of a deleterious effect upon potency as the result of action of the virus or of enzymes from the tissue-culture fluids. If enzymes with the potential to harm pertussis potency were present in some lots of DTPP, the lack of Merthiolate in the DTPP might enable the enzymes to act. It may be possible, also, that benzethonium chloride or the parabens may damage the pertussis cell wall in such a way that enzymes are then able to act upon the protective antigen.
However, the instability of pertussis vaccines preserved with benzethonium chloride, which has been clearly demonstrated, is sufficient by itself to explain the loss of potency of the pertussisvaccine component of DTPP.
